Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
Go back to Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer| CARA THERAPEUTICS (NASDAQ: CARA) | Delayed: 5.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $17.69 | |||
| Open | $5.32 | 52 Week Low | $4.26 | |||
| Day High | $5.32 | P/E | N/A | |||
| Day Low | $5.32 | EPS | $-0.42 | |||
| Volume | 1,000 | |||||
| (NASDAQ: IOVA) | Delayed: 8.45 +0.17 (2.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.28 | 52 Week High | $ | |||
| Open | $8.31 | 52 Week Low | $ | |||
| Day High | $8.69 | P/E | N/A | |||
| Day Low | $8.30 | EPS | $ | |||
| Volume | 3,423,091 | |||||
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 47.86 +0.36 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.50 | 52 Week High | $4.38 | |||
| Open | $48.00 | 52 Week Low | $1.88 | |||
| Day High | $49.03 | P/E | N/A | |||
| Day Low | $47.85 | EPS | $-1.12 | |||
| Volume | 28,063 | |||||
